Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$2.83 - $6.99 $6,625 - $16,363
-2,341 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$3.18 - $7.0 $1,036 - $2,282
-326 Reduced 12.22%
2,341 $7,000
Q4 2019

Feb 04, 2020

BUY
$3.46 - $7.7 $3,390 - $7,546
980 Added 58.09%
2,667 $17,000
Q3 2019

Nov 12, 2019

BUY
$2.8 - $3.99 $4,723 - $6,731
1,687 New
1,687 $6,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0

About RVL Pharmaceuticals plc


  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.